NIR Light-Activated Drug Release for Synergetic Chemo-Photothermal Therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• PEGylated liposomes enhance tumor drug accumulation but lack active drug release mechanisms.
• Effective cancer therapy requires strategies for controlled drug delivery and localized treatment.

Purpose of the Study:

• To design and evaluate a novel liposome (DOX@PIC-Lipo) for synergistic chemo-photothermal cancer therapy.
• To enable active drug release and hyperthermia generation upon near-infrared (NIR) laser irradiation.

Main Methods:

• Development of PEG-IR780-C13 (PIC) inserted liposomes encapsulating doxorubicin (DOX).
• Assessment of photothermal properties and DOX release kinetics under NIR laser irradiation.
• In vitro and in vivo evaluation of synergistic therapeutic efficacy.

Main Results:

• DOX@PIC-Lipo demonstrated efficient hyperthermia generation and facilitated DOX release upon NIR laser stimulation.
• Synergistic therapeutic effects were observed in both in vitro cancer cell models and in vivo tumor models.
• The novel liposomal formulation showed enhanced anti-cancer activity compared to conventional methods.

Conclusions:

• DOX@PIC-Lipo offers an active drug release strategy for combined chemo-photothermal therapy.
• This approach holds promise for improving cancer treatment efficacy and reducing systemic side effects.
• The developed nanocarrier system represents a potential advancement in targeted cancer therapy.